Document Detail


Dietary docosahexaenoic acid levels influence the outcome of arabinosylcytosine chemotherapy in L1210 leukemic mice.
MedLine Citation:
PMID:  12734065     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The purpose of this study was to investigate whether dietary supplementation with the n-3 fatty acid docosahexaenoic acid (DHA) in combination with arabinosylcytosine (AraC) chemotherapy could prolong the life expectancy of mice bearing L1210 leukemia. The four control diets included rodent chow, a diet containing 5% of a blended oil mimicking the fatty acid composition of rodent chow, and diets containing 5% or 10% fat with safflower oil as the main oil source. The two DHA-supplemented diets provided 1.5% or 3.5% DHA and 5% or 10% total fat, respectively. After tumor cell inoculation, mice were treated with AraC for 10 days. Mice fed the 5% safflower oil diet (30.1 -/+ 4.1 days), but not those fed the 10% safflower oil diet, survived longer than the chow-fed animals (22.1 -/+ 3.1 days, P = 0.05). The 1.5%-/+ DHA diet (average intake 1.8 g DHA/kg/day) was associated with a longer life span (33.3 -/+ 3.4 days, P < 0.01 vs. chow-fed) and no incidence of death due to drug toxicity. Further increasing DHA intake (4.5 g DHA/kg/day) resulted in shortened survival time (26.5 -/+ 2.0 days), increased circulating tumor cell burden, and lowered red blood cell concentrations. These data suggest that a modest level of dietary DHA or linoleic acid supplementation may improve the antineoplastic efficacy of AraC. However, overconsumption of DHA reverses the beneficial effect of DHA intake on drug sensitivity.
Authors:
Ming C Cha; Kelly A Meckling; Christine Stewart
Related Documents :
9237935 - Dietary supplementation with gamma-linolenic acid alters fatty acid content and eicosan...
20206485 - Elevated plasma fibrinogen caused by inadequate alpha-linolenic acid intake can be redu...
20551965 - Effects of weight loss and seafood consumption on inflammation parameters in young, ove...
10812585 - Triglyceride-lowering effect of omega-3 lc-polyunsaturated fatty acids--a review.
8139395 - Lipid peroxidation and antioxidant status is affected by different vitamin e levels whe...
2610725 - Effect of metoprolol on plasma lipids and arterial intimal lipid deposition in spontane...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Nutrition and cancer     Volume:  44     ISSN:  0163-5581     ISO Abbreviation:  Nutr Cancer     Publication Date:  2002  
Date Detail:
Created Date:  2003-05-07     Completed Date:  2003-12-12     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7905040     Medline TA:  Nutr Cancer     Country:  United States    
Other Details:
Languages:  eng     Pagination:  176-81     Citation Subset:  IM    
Affiliation:
Department of Human Biology and Nutrition Sciences, University of Guelph, Guelph, ON, Canada N1G 2W1.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antimetabolites, Antineoplastic / blood,  therapeutic use*
Cytarabine / blood,  therapeutic use*
Dietary Supplements / statistics & numerical data*
Docosahexaenoic Acids / administration & dosage,  blood,  pharmacology*
Erythrocyte Count / statistics & numerical data
Leukemia L1210 / blood,  drug therapy*,  mortality
Leukocyte Count / statistics & numerical data
Male
Mice
Organ Size / drug effects
Platelet Count / statistics & numerical data
Treatment Outcome
Chemical
Reg. No./Substance:
0/Antimetabolites, Antineoplastic; 147-94-4/Cytarabine; 25167-62-8/Docosahexaenoic Acids

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Adequate intakes of vitamin E and protein prevent increases of oxidative damage to DNA, lipids, and ...
Next Document:  Antitumor activity of milk kefir and soy milk kefir in tumor-bearing mice.